|
Session 94
Poster Abstracts
Predictors of Immunologic Recovery on ART
Tuesday, 1 - 4 pm
Poster Hall |
518
 |
Predictors for CD4 Cell Count Increase for Patients with Sustained Viral Load Suppression within 1 Year after Starting cART: The Swiss HIV Cohort Study
M Wolbers1, M Battegay2, B Hirschel3, H Furrer4, M Cavassini5, R Weber6, P Vernazza7, E Bernasconi8, G Kaufmann2, Heiner C. Bucher*1,2, Heiner C. Bucher*1,2, and The Swiss HIV cohort study (SHCS)
1Basel Inst for Clin Epidemiology, Switzerland; 2Univ Hosp Basel, Switzerland; 3Univ Hosp Geneva, Switzerland; 4Univ Hosp Berne, Switzerland; 5Univ Hosp Lausanne, Switzerland; 6Univ Hosp, Zurich, Switzerland; 7Cantonal Hosp, St Gall, Switzerland; and 8Regional Hosp Lugano, Switzerland |
| 519 |
Normalization of CD4 Counts in Patients Taking Combination ART with Maximum Virologic Suppression
Amanda Mocroft*1, A Phillips1, J Gatell2, B Ledergerber3, M Fisher4, N Clumeck5, M Losso6, A Lazzarin7, G Fätkenheuer8, J Lundgren9, and the EuoSIDA Study Group
1Royal Free and Univ Coll London Med Sch, UK; 2Hosp Clin i Provincial, Barcelona, Spain; 3Univ Hosp, Zurich, Switzerland; 4Royal Sussex County Hosp, Brighton, UK; 5St Pierre Hosp, Brussels, Belgium; 6Hosp JM Ramos Mejia, Buenos Aires, Argentina; 7Hosp San Raffaele, Milan, Italy; 8Univ Cologne, Germany; and 9Copenhagen HIV Prgm, Hvidovre, Denmark |
| 520 |
Adherence Levels, Virological Responses, and Immunological Outcomes among Patients Initiating cART in the VA Healthcare System
Scott Braithwaite*1, M Kozal1, C Chang2, M Roberts2, S Fultz1, M Goetz3, C Gibert4, M Rodriguez-Barradas5, L Mole6, and A Justice1
1Yale Univ, New Haven, CT, US; 2Univ of Pittsburgh, PA, US; 3Univ of California, Los Angeles, US; 4George Washington Univ Med Ctr, Washington, DC, US; 5Baylor Coll of Med, Houston, TX, US; and 6VA Ctr for Quality Mgmt in Publ Hlth, Palo Alto, CA, US |
| 521 |
Immuologic Recovery among Virologically Suppressed HIV-infected Patients in Western India
Sanjay Pujari*1,2, Sanjay Pujari*1,2, N Gupte3, S Mellinkeri1, E Naik2, L Menezes2, and J Sinnott2
1Inst of Infectious Diseases, Pune, India; 2Univ of South Florida, Tampa, US; and 3Pune, India |
|
